Sue Barrowcliffe
About Sue Barrowcliffe
Sue Barrowcliffe serves as the General Manager for Europe at Aimmune Therapeutics, a position she has held since 2016. She earned a Bachelor of Science degree in Biochemistry from The University of Sheffield between 1977 and 1980.
Work at Aimmune Therapeutics
Sue Barrowcliffe has served as the General Manager for Europe at Aimmune Therapeutics since 2016. In this role, she oversees the company's operations and strategic initiatives within the European market. Her leadership contributes to the advancement of Aimmune's mission in the field of immunotherapy.
Education and Expertise
Sue Barrowcliffe earned a Bachelor of Science degree in Biochemistry from The University of Sheffield, where she studied from 1977 to 1980. This academic background provides her with a solid foundation in the scientific principles that underpin her work in the biotechnology sector.
Background
With over eight years of experience at Aimmune Therapeutics, Sue Barrowcliffe has developed a deep understanding of the European healthcare landscape. Her role as General Manager involves navigating complex regulatory environments and fostering relationships with key stakeholders in the industry.
Achievements
During her tenure at Aimmune Therapeutics, Sue Barrowcliffe has played a significant role in expanding the company's presence in Europe. Her efforts have focused on driving business growth and enhancing the accessibility of innovative therapies for patients in the region.